Discontinued — last reported Q2 '24
Non-Current Assets
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)
Biogen Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) increased by 8.7% to $455.90M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) shows a downward trend with a -16.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ2 2024
How to read this metric
Higher values indicate a larger pool of medium-term liquid assets, while lower values suggest a shorter or longer duration profile in the investment portfolio.
Detailed definition
This metric represents the fair value of debt securities classified as available-for-sale that have a contractual maturi...
Peer comparison
Standard for companies with significant cash reserves or captive finance operations managing interest rate risk.
Metric ID:
afs_debt_securities_fair_value_maturing_1_to_5yHistorical Data
11 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $870.90M | $925.50M | $870.20M | $982.90M | $1.09B | $848.30M | $703.70M | $965.80M | $1.20B | $419.30M | $455.90M |
| QoQ Change | — | +6.3% | -6.0% | +13.0% | +10.8% | -22.1% | -17.0% | +37.2% | +24.5% | -65.1% | +8.7% |
| YoY Change | — | — | — | — | +25.1% | -8.3% | -19.1% | -1.7% | +10.4% | — | — |
Range$419.30M – $1.20B
CAGR-22.8%
Avg YoY Growth+1.3%
Median YoY Growth-1.7%
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) at Other Companies
Frequently Asked Questions
- What is Biogen's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Biogen (BIIB) reported available-for-sale debt securities - fair value (maturing 1 to 5 years) of $455.90M in Q1 2026.
- What is the long-term trend for Biogen's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Over 3 years (2020 to 2025), Biogen's available-for-sale debt securities - fair value (maturing 1 to 5 years) has grown at a -16.5% compound annual growth rate (CAGR), from $721.30M to $419.30M.
- What does available-for-sale debt securities - fair value (maturing 1 to 5 years) mean?
- The market value of debt investments maturing in one to five years that are not held for immediate trading.